|
|
Pacemaker |
|
Cellular Phone Interference |
|
|
Consumer Information for the Medtronic InSync Biventricular Pacing System |
|
|
Dear Colleague Letter: Interaction Between Minute Ventilation Rate-Adaptive Pacemakers and Cardiac Monitoring and Diagnostic Equipment |
|
|
FDA Approves First Pacemaker For Congestive Heart Failure |
|
|
FDA Approves New Type of Pacemaker |
|
|
Important Information on Anti-Theft and Metal Detector Systems and Pacemakers, ICDs, and Spinal Cord Stimulators |
|
|
Pacing Systems |
|
FDA Approves First Pacemaker For Congestive Heart Failure |
|
|
FDA Approves New Type of Pacemaker |
|
|
Pain |
|
Guidance for Studies for Pain Therapy Devices - General Consideration in the Design of Clinical Studies for Pain-Alleviating Devices |
|
|
|
Panel Meetings |
|
Brochure: Request for Nominations for Members and Consultants to Serve on FDA's Medical Devices Advisory Committee |
|
|
|
Guidance on Amended Procedures for Advisory Panel Meetings; Final |
|
|
|
Industry Representatives on Scientific Panel |
|
|
|
Overview with Links to Upcoming Meetings and Summaries of Recent Meetings |
|
|
Panel Report and Recommendations on PMA Approvals #P86-5 (blue book memo) |
|
|
Panel Review of 'Me-Too' Devices #P86-6 (blue book memo) |
|
|
Panel Review of Premarket Approval Applications #P91-2 (blue book memo) |
|
|
Parenteral Nutrition |
|
Hazards of Precipitation Associated With Parenteral Nutrition |
|
|
|
Parkinson's Disease |
|
FDA Approves Expanded Use of Brain Implant for Parkinson's Disease |
|
|
FDA Approves Implanted Brain Stimulator to Control Tremors |
|
|
Neurological Devices Panel, March 31, 2000 - Bilateral Deep Brain Stimulator |
|
|
Participating In Clinical Trials |
|
Clinical Trials of Medical Treatments: Why Volunteer? |
|
|
|
Partnership Program |
|
FDA Public/Private Partnership Program |
|
|
Patient Examination Gloves |
|
Draft Medical Glove Guidance Manual |
|
|
|
Guidance for Conducting Stability Testing To Support An Expiration Date Labeling Claim for Medical Gloves; Draft |
|
|
|
Surgeon's and Patient Examination Gloves; Reclassification and Medical Glove Guidance Manual Availability; Proposed Rule and Notice |
|
|
Patient Safety |
|
FDA Patient Safety News for Health Care Personnel |
|
|
Final Summary of Food and Drug Administration (FDA) Action Items - Doing What Counts for Patient Safety: Federal Actions to Reduce Medical Errors and Their Impact |
|
|
PDP |
|
PDP - see Product Development Protocol |
|
|
|
Pediatric |
|
Pediatric Medical Devices |
|
|
Premarket Assessment of Pediatric Medical Devices - Guidance for Industry and FDA Staff |
|
|
|
Presentation/Transcript - American Academy of Pediatrics: Improving the Availability of Pediatric Devices - June 28, 2004 |
|
|
Pelvic |
|
Guidance for Resorbable Adhesion Barrier Devices for Use in Abdominal and/or Pelvic Surgery; Guidance for Industry |
|
|
|
Penalties |
|
Civil Money Penalty Policy |
|
|
|
Reduction of Civil Money Penalties for Small Entities; Guidance for Industry and FDA Staff |
|
|
|
Penile Devices |
|
CDRH Interim Regulatory Policy for External Penile Rigidity Devices |
|
|
Draft Guidance for Preparation of PMA Applications for Penile Inflatable Implants |
|
|
Guidance for the Content of Premarket Notifications for Penile Rigidity Implants; Final |
|
|
|
Performance Plans |
|
FDA Performance Plan FY2002 - Medical Devices and Radiological Health |
|
|
FDA's FY 2001 Performance Plan, FY 2000 Final Performance Plan, and FY 1999 Performance Report for Medical Devices and Radiological Health |
|
|
Pesticides |
|
Pesticide Regulation Notice 94-4 Interim Measures for the Registration of Antimicrobial Products/Liquid Chemical Germicides with Medical Device Use Claims |
|
|
|
Petitions |
|
CDRH Petitions |
|
|
Photon-emitting Devices |
|
Guidance for the Submission of Premarket Notifications for Photon-Emitting Brachytherapy Sources |
|
|
|
Photorefractive Keratectomy (PRK) |
|
FDA Approves Laser for LASIK |
|
|
Lasik Updates |
|
|
LASIK Eye Surgery |
|
|
Summary Information for LaserScan LSX Excimer Laser System for Photorefractive Keratectomy for Myopia |
|
|
Picture Archiving and Communications Systems (PACS) |
|
Guidance for the Submission of Premarket Notifications for Medical Image Management Devices |
|
|
|
PMA |
|
PMA - See Premarket Approval |
|
|
|
Pneumonia |
|
FDA Clears Quick New Lab Test for Pneumonia Antigen |
|
|
Policy Development |
|
Policy Development and Review Procedures #I90-1 (blue book memo) |
|
|
Polymer Implants |
|
Guidance Document for Testing Biodegradable Polymer Implant Devices |
|
|
Porous Coated |
|
Class II Special Controls Guidance: Shoulder Joint Metal/Polymer/Metal Nonconstrained or Semi-Constrained Porous-Coated Uncemented Prosthesis |
|
|
|
Portable Document Format (PDF) Reader |
|
Helpful Tips for CDRH Documents in PDF Format |
|
|
Instructions for Downloading Portable Document Format (PDF) Reader |
|
|
Postmarket Surveillance |
|
Amendment to Guidance on Discretionary Postmarket Surveillance on Pacemaker Leads |
|
|
|
Appendix A: Final Report of a Study To Evaluate the Feasibility and Effectiveness of a Sentinel Reporting System for Adverse Event Reporting of Medical Device Use in User Facilities |
|
|
|
Designing a Medical Device Surveillance Network: A Report To Congress |
|
|
|
Guidance on Criteria and Approaches for Postmarket Surveillance |
|
|
|
Guidance on Procedures for Review of Postmarket Surveillance Submissions |
|
|
|
Guidance on Procedures to Determine Application of Postmarket Surveillance Strategies |
|
|
|
Presentation: Gaps in Your Postmarket Safety Net for Medical Devices |
|
|
|
|
SMDA to FDAMA: Guidance on FDA's Transition Plan for Existing Postmarket Surveillance |
|
|
|
The Role of Clinical Data in Postmarket Surveillance of Cardiovascular Devices - Workshop Summary |
|
|
|
Powered Muscle Stimulators |
|
Guidance Document for Powered Muscle Stimulator 510(k)s; Final |
|
|
|
Pre-IDE |
|
Pre-IDE Program: Issues and Answers - Blue Book Memo D99-1 |
|
|
|
Preamendments Devices |
|
515(i) Reclassification Letter to Manufacturers |
|
|
Document Required for Preamendment Status |
|
|
Preamendment Class III Devices |
|
|
|
Preamendments Class III Strategy |
|
|
Pregnancy |
|
Pregnancy Home Use Test |
|
|
Premarket Approval |
|
Blue Book Memoranda - PMA |
|
|
PMA Modular Submission Cover Sheet at HIMA Website |
|
|
|
30-Day Notices and 135-Day PMA Supplements for Manufacturing Method or Process Changes (2/19/98) (P98-4) |
|
|
30-Day Notices and 135-day PMA Supplements for Manufacturing Method or Process Changes, Guidance for Industry and CDRH (Docket 98D-0080); Final |
|
|
|
4-of-A-Kind PMAs |
|
|
|
Acceptance of Foreign Clinical Studies; Guidance for Industry |
|
|
|
Bundling Multiple Devices or Multiple Indications in a Single Submission - Guidance for Industry and FDA Staff |
|
|
|
Clinical Utility and Premarket Approval #P91-1 (blue book memo) |
|
|
Continued Access to Investigational Devices During PMA Preparation and Review (Blue Book Memo) (D96-1) |
|
|
Criteria for Panel Review of PMA Supplements #P86-3 (blue book memo) |
|
|
Device Advice: PMA Supplements and Amendments |
|
|
Distribution and Public Availability of PMA Summary of Safety and Effectiveness Data Packages |
|
|
Draft Guidance: Likelihood of Facilities Inspections When Modifying Devices Subject to Premarket Approval |
|
|
|
Early Collaboration Meetings Under the FDA Modernization Act (FDAMA) (2/19/98 (P98-3) |
|
|
Expedited Review of Premarket Submissions for Devices - Guidance for Industry and FDA Staff |
|
|
|
FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Performance Assessment - Guidance for Industry and FDA Staff |
|
|
|
FDA Launches Initiative to Improve the Development and Availability of Innovative Medical Products |
|
|
Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent Deficiencies (2/19/1998) (P98-2) |
|
|
Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent Deficiencies - for Use by CDRH and Industry; Final |
|
|
|
Guidance on Section 216 of the Food and Drug Administration Modernization Act of 1997 |
|
|
|
Guidance to Industry Supplements to Approved Applications for Class III Medical Devices: Use of Published Literature, Use of Previously Submitted Materials, and Priority Review; Final |
|
|
Improving Innovation in Medical Technology: Beyond 2002 |
|
|
Improving Innovation in Medical Technology: Beyond 2002 - Executive Summary |
|
|
In Vitro Diagnostic Model for a Pilot for Streamlined PMA Review |
|
|
Information About Applications with a Link to Releasable PMAs |
|
|
Letter to IVD Manufacturers on Streamlined PMA; Final |
|
|
|
Modifications to Devices Subject to Premarket Approval - The PMA Supplement Decision Making Process; Draft |
|
|
|
New IDE / PMA Development and Review Model and Pilots |
|
|
New Model Medical Device Development Process; Final |
|
|
Panel Review of Premarket Approval Applications #P91-2 (blue book memo) |
|
|
PMA Compliance Program #P91-3 (blue book memo) |
|
|
PMA Review Schedules (P87-1) Replaced by P94-2 |
|
|
PMA Review Statistical Checklist |
|
|
|
PMA Supplements: ODEs letter to manufacturers; identifies situations which may require the submission of a PMA supplement (When PMA Supplements are Required) #P90-1 (blue book memo) |
|
|
PMA Transformation Team Home Page |
|
|
PMA/510(k) Triage Review Procedures #G94-1 (blue book memo) |
|
|
PMAs - Early Review and Preparation of Summaries of Safety and Effectiveness #P86-1 (blue book memo) |
|
|
Premarket Approval (PMA) Manual |
|
|
|
Premarket Approval Application (PMA) Closure #P94-2 (blue book memo) |
|
|
Premarket Approval Application Content Shell |
|
|
Premarket Approval Application Filing Review - Guidance for Industry and FDA Staff |
|
|
|
| |
|
|
Premarket Approval Application Modular Review - Guidance for Industry and FDA Staff |
|
|
|
Premarket Approval Applications (PMA) for Absorbable Powder for Lubricating a Surgeon’s Glove - Guidance for Industry and FDA Staff |
|
|
|
Premarket Approval Search Engine |
|
|
Premarket Assessment of Pediatric Medical Devices - Guidance for Industry and FDA Staff |
|
|
|
Quality System Information for Certain Premarket Application Reviews; Guidance for Industry and FDA Staff |
|
|
|
Real-Time Review Program for Premarket Approval Application (PMA) Supplements |
|
|
|
Review and Approval of PMAs of Licensees #P86-4 (blue book memo) |
|
|
SMDA Changes - PMA Manual Insert |
|
|
|
Threshold Assessment of the Impact of Requirements for Submission of PMAs for 31 Medical Devices Marketed Prior to May 28, 1976 |
|
|
|
User Fees and Refunds for Premarket Approval Applications - Guidance for Industry and FDA Staff |
|
|
|
Premarket Notification (510(k)) |
|
510(k) Manual - Premarket Notification: 510(k) - Regulatory Requirements for Medical Devices |
|
|
510(k) Additional Information Procedures #K93-1 (blue book memo) |
|
|
510(k) Quality Review Program (blue book memo) |
|
|
510(k) Refuse to Accept Procedures #K94-1 (blue book memo) |
|
|
510(k) Sign-Off Procedures #K94-2 (blue book memo) |
|
|
A New 510(k) Paradigm - Alternate Approaches to Demonstrating Substantial Equivalence in Premarket Notifications |
|
|
|
Center for Biologics Evaluation and Research - Substantially Equivalent 510(k) Device Information |
|
|
Center for Devices and Radiological Health's Premarket Notification [510(k)] Refuse to Accept Policy - (updated Checklist 3/14/1995) |
|
|
|
Deciding When to Submit a 510(k) for a Change to an Existing Device (K97-1) |
|
|
|
Determination of Intended Use for 510(k) Devices; Guidance for CDRH Staff |
|
|
|
| |
|
|
FDA and Industry Actions on Premarket Notification (510(k)) Submissions: Effect on FDA Review Clock and Performance Assessment - Guidance for Industry and FDA Staff |
|
|
|
Frequently Asked Questions on the New 510(k) Paradigm; Final |
|
|
|
Guidance for Third Parties and FDA Staff; Third Party Review of Premarket Notifications |
|
|
|
Guidance on the Center for Devices and Radiological Health's Premarket Notification Review Program #K86-3 (blue book memo) |
|
|
In Vitro Diagnostic Devices: Guidance for the Preparation of 510(k) Submissions |
|
|
Indications for Use Statement |
|
|
|
Information on Releasable 510(k)s |
|
|
List of Accredited Persons for 510(k) Review under the FDA Modernization Act of 1997 |
|
|
Medical Device Exemptions: 510(k) and GMP Requirements |
|
|
New section 513(f)(2) - Evaluation of Automatic Class III Designation: Guidance for Industry and CDRH Staff; Final |
|
|
|
PMA/510(k) Triage Review Procedures #G94-1 (blue book memo) |
|
|
Premarket Assessment of Pediatric Medical Devices - Guidance for Industry and FDA Staff |
|
|
|
Premarket Notification - Consistency of Reviews #K89-1 (blue Book memo) |
|
|
Premarket Notification [510(k)] Status Request Form |
|
|
|
Premarket Submission Cover Sheet |
|
|
|
|
Procedures for Class II Device Exemptions from Premarket Notification Guidance for Industry and CDRH Staff; Final |
|
|
|
Required Elements for a Declaration of Conformity to a Recognized Standard - (Screening Checklist for All Premarket Notification [510(k)] Submissions) |
|
|
|
Screening Checklist for all Premarket Notification 510(k) Submissions |
|
|
|
Search the Releasable 510(k) Database |
|
|
Sec. 300.600 Commercial Distribution with Regard to Premarket Notification [Section 510(k)] [CPG 7124.19] |
|
|
SMDA Changes - Premarket Notification; Regulatory Requirements for Medical Devices (510k) Manual Insert |
|
|
|
Updated 510(k) Sterility Review Guidance K90-1; Final Guidance for Industry and FDA |
|
|
|
User Fees and Refunds for Premarket Notification Submissions (510(k)s) - Guidance for Industry and FDA Staff |
|
|
|
Premarket Review |
|
A Systems Approach to Premarket Review |
|
|
|
Presentations |
|
Presentations by CDRH Staff |
|
|
Process Validation |
|
Guideline on General Principles of Process Validation |
|
|
|
Product Classification |
|
Product Classification Database |
|
|
Product Development Protocol (PDP) |
|
Guidance for Industry - Contents of a Product Development Protocol; Draft |
|
|
|
Product Development Protocol |
|
|
Product Evaluation |
|
Documentation and Resolution of Differences of Opinion on Product Evaluations #G93-1 (blue book memo) |
|
|
Prostate |
|
Draft Guidance for Clinical Investigations of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH) |
|
|
Elecsys® Free PSA Immunoassay, Elecsys® Free PSA CalSet, Elecsys® Free PSA CalCheck P000027 |
|
|
FDA Approves New Device to Treat Enlarged Prostate |
|
|
FDA Approves Test for Prostate Cancer |
|
|
FDA Public Health Notification: Serious Injuries from Microwave Thermotherapy for Benign Prostatic Hyperplasia |
|
|
|
Prostate Cancer: No One Answer for Testing or Treatment |
|
|
Summary Information on Elecsys ® Total PSA Immunoassay and Total PSA Calset - P990056 |
|
|
Prostate Cancer |
|
Elecsys® Free PSA Immunoassay, Elecsys® Free PSA CalSet, Elecsys® Free PSA CalCheck P000027 |
|
|
FDA Approves New Device to Treat Enlarged Prostate |
|
|
FDA Approves Test for Prostate Cancer |
|
|
FDA Public Health Notification: Serious Injuries from Microwave Thermotherapy for Benign Prostatic Hyperplasia |
|
|
|
Prostate Cancer: No One Answer for Testing or Treatment |
|
|
Summary Information on Elecsys ® Total PSA Immunoassay and Total PSA Calset - P990056 |
|
|
Prostheses |
|
Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis |
|
|
|
Prothrombin Time |
|
Prothrombin Time Home Use Test |
|
|
Publications |
|
Catalog of FDA Information for Consumers - Publications and Audiovisuals |
|
|
FDA & YOU - News for Health Educators and Students |
|
|
Mammography Matters |
|
|
User Facility Reporting Bulletins |
|
|
Pumps |
|
Guidance Document for Powered Suction Pump 510(k)s |
|
|
|
Guidance on the Content of Premarket Notification [510(k)] Submissions for External Infusion Pumps |
|
|
Medtronic IsoMed Constant Flow Infusion System |
|
|
|
PVC |
|
Consumer Update - DEHP in Plastic Medical Devices |
|
|
FDA Public Health Notification: PVC Devices Containing the Plasticizer DEHP |
|
|
|
Medical Devices Made With Polyvinylchloride (PVC) Using the Plasticizer di-(2-Ethylhexyl)phthalate (DEHP); Draft Guidance for Industry and FDA |
|
|
|
Presentation: PVC and DEHP |
|
|
|
|
Safety Assessment of di-(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices |
|
|
|
|